Table 1.
Study | Country (ethnicity) | Source of control | Methods | miRNA SNP | Number of subjects | Case
|
Control
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
TT/GG | CT/CG | CC/CC | TT/GG | CT/CG | CC/CC | ||||||
Yin et al21 | Chinese (Asian) | H | TaqMan PCR | 196a2 rs11614913 | 1,183 | 149 | 298 | 128 | 178 | 297 | 133 |
Shang et al22 | Chinese (Asian) | P | PCR-RFLP | 196a2 rs11614913 | 116 | 7 | 17 | 8 | 48 | 26 | 10 |
Yin et al23 | Chinese (Asian) | H | TaqMan PCR | 196a2 rs11614913 | 568 | 67 | 141 | 50 | 97 | 150 | 63 |
Vinci et al16 | Italian (Caucasian) | H | PCR-HRMA | 196a2 rs11614913 | 230 | 12 | 54 | 35 | 10 | 61 | 58 |
Hong et al24 | Korean (Asian) | P | TaqMan PCR | 196a2 rs11614913 | 834 | 96 | 224 | 86 | 134 | 198 | 96 |
Kim et al25 | Korean (Asian) | H | Fluorescence | 196a2 rs11614913 | 1,294 | 162 | 305 | 187 | 185 | 300 | 155 |
Tian et al26 | Chinese (Asian) | P | PCR-RFLP | 196a2 rs11614913 | 2,093 | 293 | 512 | 253 | 307 | 519 | 209 |
Yin et al21 | Chinese (Asian) | H | TaqMan PCR | 146a rs2910164 | 1,183 | 97 | 280 | 198 | 127 | 313 | 168 |
Yin et al23 | Chinese (Asian) | H | TaqMan PCR | 146a rs2910164 | 568 | 45 | 134 | 79 | 63 | 160 | 87 |
Jia et al27 | Chinese (Asian) | H | PCR-RFLP | 146a rs2910164 | 800 | 64 | 182 | 154 | 76 | 200 | 124 |
Jeon et al28 | Korean (Asian) | P | PCR-RFLP | 146a rs2910164 | 2,187 | 223 | 500 | 368 | 244 | 540 | 312 |
Vinci et al16 | Italian (Caucasian) | H | PCR-HRMA | 146a rs2910164 | 230 | 44 | 48 | 9 | 73 | 45 | 11 |
Tian et al26 | Chinese (Asian) | P | PCR-RFLP | 146a rs2910164 | 2,093 | 360 | 510 | 188 | 364 | 502 | 169 |
Abbreviations: miRNA, microRNA; SNP, single-nucleotide polymorphism; P, population; H, hospital; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; HRMA, high resolution melting analysis.